An observational study in Acute Inflammatory Demyelinating Polyradiculoneuropathy, Stroke and Anosognosia, sponsored by Hadassah Medical Organization. Not yet recruiting. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-03-29.
Sponsored by Hadassah Medical Organization · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The main objective of the study is to explore and map brain areas involved in processing and perception in patients suffering from neurological pathologies and condition. The investigators hypothesize for example, that a change (compare to healthy subjects) in the perceptual maps and body representation could be detected and characterize in patients suffering from impairments of peripheral nerve conduction.
98 studies on the registry are indexed under Guillain-Barre Syndrome; 30 are open to participants now.
This study's planned enrollment of 150 is above the median of 101 across 48 observational studies indexed under Guillain-Barre Syndrome.
Browse Guillain-Barre Syndrome studies →Hadassah Medical Organization is the lead sponsor of 675 studies on the registry; 54 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients suffering from central and peripheral neurological pathologies and conditions
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Age matched control for the various clinical groups
Device: 3 Tesla Siemens Skyra MRI scanner
Device: 3 Tesla Siemens Skyra MRI scanner
Device: 3 Tesla Siemens Skyra MRI scanner
Device: 3 Tesla Siemens Skyra MRI scanner
Standardly used Magnetic resonance imaging (MRI) protocols, including resting state fMRI, task fMRI, T1 weighted imaging
Hemodynamic responses by measurement of the Blood-oxygen-level dependence(BOLD) signal
Distinct maps of sensory and multisensory representations related to certain disorders will be sassed by measurement of the Blood-oxygen-level dependence(BOLD) signal.
Time frame: 2 years
No study locations are listed for this record.
Plan to share: No
The record gives a start of Mar 2016, a primary completion of Mar 2020 and a completion of Mar 2025. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hadassah Medical Organization →